Vytrus Biotech, S.A. (BME:VYT)

Spain · Delayed Price · Currency is EUR

17.55

-0.05 (-0.28%)

Last updated: Aug 7, 2026, 11:34 AM CET

Vytrus Biotech Financials Overview

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	8.37	8.37	5.04	3.74	3.68	2.8
Revenue Growth	20.98%	65.95%	35.00%	1.48%	31.31%	64.49%
Gross Profit	7.46	7.46	4.52	3.26	3.29	2.51
Operating Income	3.18	3.18	1	0.45	0.64	0.43
Net Income	2.9	2.9	1.02	0.54	0.61	0.45
Earnings Per Share	0.38	0.38	0.13	0.08	0.09	0.06
EPS Growth	47.34%	192.31%	62.50%	-11.11%	50.00%	100.00%

Revenue by Geography

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Spain	2.59	2.59	1.51	1.47	1.26	1.03
European Union	2.62	2.62	1.67	1.09	1.38	1.2
Other Export	3.17	3.17	1.87	1.18	1.05	0.57
Total	8.37	8.37	5.04	3.74	3.68	2.8

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	6.88	6.88	5.06	1.11	0.72	2.57
Total Debt	3.95	3.95	4.95	2.85	2.02	3.77
Net Cash (Debt)	2.93	2.93	0.1	-1.75	-1.3	-1.21
Net Cash Growth	48.13%	2704.82%	-	-	-	-
Net Cash Per Share	0.38	0.38	0.01	-0.25	-0.18	-0.17

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	3.9	3.9	1.84	0.9	1.03	0.45
Capital Expenditures	-1.01	-1.01	-0.1	-0.14	-0.42	-0.22
Free Cash Flow	2.89	2.89	1.74	0.76	0.61	0.23
Free Cash Flow Growth	6.88%	65.63%	128.46%	25.94%	166.43%	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	89.16%	89.16%	89.63%	87.29%	89.25%	89.51%
Operating Margin	37.99%	37.99%	19.92%	12.16%	17.51%	15.32%
Pretax Margin	37.34%	37.34%	17.87%	8.25%	12.30%	11.02%
Profit Margin	34.60%	34.60%	20.24%	14.58%	16.44%	16.05%
FCF Margin	34.48%	34.48%	34.55%	20.41%	16.45%	8.11%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 7, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	45.67	22.50	16.62	41.00	36.44	-
Forward PE	-	20.43	21.98	11.97	26.21	-
P/FCF Ratio	45.83	22.26	9.46	28.96	37.42	-
PS Ratio	13.65	7.68	3.27	5.91	6.15	-